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The Cytoplasmic Domain of the Ligand EphrinB2
Is Required for Vascular Morphogenesis
but Not Cranial Neural Crest Migration
anchored ephrinA ligands, whereas EphB receptors (and
EphA4) bind to ephrinB ligands, transmembrane pro-
teins carrying a highly conserved 80 residue cytoplasmic
domain. (reviewed in Flanagan and Vanderhaeghen,
1998; Wilkinson, 2000).
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Recent work in the mouse has demonstrated impor-D-69117 Heidelberg
tant roles for ephrinB2 and its cognate EphB receptorsGermany
in vascular development. Reciprocal expression of†Max-Planck-Institute for Physiological
ephrinB2 and EphB4 in arterial and venous endothelialand Clinical Research
cells, respectively, suggested ephrinB2-EphB4 interac-W.G. Kerckhoff Institute
tions at the arterial–venous interface (Wang et al., 1998;Bad Nauheim
Adams et al., 1999; Gerety et al., 1999). Consistently,Germany
knockout mice lacking either ephrinB2 or EphB4 die
during embryogenesis and display similar cardiovascu-
lar defects (Wang et al., 1998; Gerety et al., 1999). Angio-Summary
genic remodeling in yolk sac and embryos was defec-
tive, resulting in arrest at the primitive capillary plexusThe transmembrane ligand ephrinB2 and its cognate
stage. Partially penetrant defects in large vessel primor-Eph receptor tyrosine kinases are important regula-
dia of the embryo demonstrated a requirement fortors of vascular morphogenesis. EphrinB2 may have
ephrinB2 in some aspects of vasculogenesis (Adamsan active signaling role, resulting in bi-directional sig-
et al., 1999). Interactions between ephrinB ligands andnal transduction downstream of both ephrinB2 and
EphB receptors away from the arterial–venous interfaceEph receptors. To separate the ligand and receptor-
were suggested by overlapping expression of ephrinB1like functions of ephrinB2 in mice, we replaced the
ligand and EphB3 and EphB4 receptors on venous endo-endogenous gene by cDNAs encoding either carboxy-
thelial cells. Moreover, mesenchymal cells adjacent toterminally truncated (ephrinB2DC) or, as a control,
blood vessels were found to express EphB2 receptors,full-length ligand (ephrinB2WT). While homozygous
and somitic ephrinB ligands were in direct contact toephrinB2WT/WT animals were viable and fertile, loss of
EphB receptors on intersomitic vessels. Functional rele-the ephrinB2 cytoplasmic domain resulted in midges-
vance of these interactions was demonstrated by par-tation lethality similar to ephrinB2 null mutants (ephrin-
tially penetrant vascular defects in ephB2/ephB3 doubleB2KO). The truncated ligand was sufficient to restore
homozygous embryos (Adams et al., 1999).guidance of migrating cranial neural crest cells, but
Whereas the mechanism of ephrin/Eph signaling inephrinB2DC/DC embryos showed defects in vasculogen-
the vasculature is presently not understood, in the devel-
esis and angiogenesis very similar to those observed
oping nervous system, ephrins are repulsive guidance
in ephrinB2KO/KO animals. Our results indicate distinct
cues for navigating neuronal growth cones and migrat-
requirements of functions mediated by the ephrinB ing neural crest cells (reviewed in Holder and Klein, 1999;
carboxyterminus for developmental processes in the Wilkinson, 2000). Neural crest cells delaminate from the
vertebrate embryo. dorsolateral edge of the neural tube and migrate along
specific pathways to various destinations where they
Introduction differentiate into many different cell types, including
neurons and glia of the peripheral nervous system, con-
Morphogenesis in the embryo is controlled by signals nective and skeletal tissue of the head, and melanocytes
from the cellular environment, generated as a result of of the skin. In the head region, neural crest cells delami-
patterning processes at work in the early embryo. Eph nate from the segmented hindbrain and migrate as seg-
receptors and their ligands, the ephrins, appear to lie mental streams into the branchial arches (Kontges and
functionally at the interface between patterning and Lumsden, 1996). In Xenopus embryos, ephrinB2 and its
morphogenesis, because they regulate many of the dy- cognate receptors EphB1 and EphA4 are expressed in
namic changes that occur during this embryonic phase, adjacent neural crest streams and underlying meso-
including cell migration, axon guidance, and angiogen- derm. Overexpression of either dominant-negative Eph
esis (reviewed in Holder and Klein, 1999; Gale and Yan- receptors or wild-type ephrinB2 caused aberrant migra-
copoulos, 1999; Wilkinson, 2000). The Eph receptor fam- tion of crest cells, presumably because the expression
ily is part of the large superfamily of receptor tyrosine of repulsive guidance cues had been altered (Smith et
al., 1997). Similarly, migration of trunk neural crest cells,kinases and is subdivided into two structurally distinct
which express EphB receptors, is guided in vitro bysubclasses, which differ in their ligand binding specifici-
repulsive ephrinB ligands expressed in posterior halfties. EphA receptors bind to glycosylphosphatidyl-
somites (Krull et al., 1997; Wang and Anderson, 1997).
These studies provided compelling evidence for a role of‡ To whom correspondence should be addressed (e-mail: klein@
ephrin/Eph signaling in neural crest migration, althoughembl-heidelberg.de).
corroborating data from genetic loss-of-function analy-§ Present address: Imperial Cancer Research Fund, London WC2A
3PX, United Kingdom. ses were still missing.
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Increasing evidence suggests that transmembrane
ephrin ligands have intrinsic signaling capability. Thus,
cell contact–induced interaction between ephrinB li-
gands and Eph receptors can trigger bidirectional sig-
nals into both cells, via classical forward signaling medi-
ated by the tyrosine kinase domain of the Eph receptor
and via nonconventional reverse signaling mediated by
the ephrinB cytoplasmic domain (reviewed in Holder
and Klein, 1999; Wilkinson, 2000). Soluble artificially
clustered EphB ectodomains induce rapid phosphoryla-
tion of conserved tyrosine residues in the cytoplasmic
part of ephrinB molecules, thereby presumably creating
docking sites for phosphotyrosine binding proteins.
Moreover, ephrinB ligands and Eph receptors carry con-
served carboxyterminal binding motifs for PDZ domain–
containing proteins, which might have roles in cell sur-
face localization, clustering, and/or signaling (reviewed
in Holder and Klein, 1999; Wilkinson, 2000). Ephrins are
localized in lipid raft microdomains, which are sites of
interaction with PDZ-domain proteins and the Fyn tyro-
sine kinase (Bru¨ckner et al., 1999; Davy et al., 1999).
EphB2 receptors are required for the formation of the
anterior commissure (AC), a forebrain axon tract (Hen-
kemeyer et al., 1996). To exert this function, EphB2 re-
ceptors do not require an active kinase domain and may
induce ephrinB reverse signaling in AC axons (Henke-
meyer et al., 1996). More recently, ephrin reverse signaling
was shown to be sufficient for cell sorting at hindbrain
segment boundaries in the Zebrafish embryo and bidirec-
tional signaling restricted cell intermingling in the fish
animal cap assay (Mellitzer et al., 1999; Xu et al., 1999).
Here, we describe the phenotype of knockin mutant
mice in which endogenous ephrinB2 was replaced by mu-
tant ephrinB2 lacking its cytoplasmic part (ephrinB2DC).
EphrinB2DC is functionally restricted to induce forward
signaling by Eph receptors on adjacent cells, but is no
longer able to exert reverse signaling via its cytoplasmicFigure 1. Generation of ephrinB2 cDNA Knockin Mutants
domain. We demonstrate that ephrinB2DC mediates(A) Schematic representation of the mouse ephrinB2 gene with the
branchial arch morphogenesis and aortic arch formationfirst exon (gray box) that contains the 59 end of the open reading
frame. cDNAs (white boxes), encoding either (a) carboxyterminally by guiding migrating neural crest cells. In this process,
truncated ephrinB2DC or (b) full-length ephrinB2WT ligand were fused ephrinB2 serves primarily as a ligand for Eph receptors
in frame with the first exon and thereby placed under control of the expressed in neural crest cells. In contrast, angiogenic
endogenous gene promoter. The transmembrane region (black box)
remodeling and the formation of major embryonic ves-and the following 14 amino acid residues were preserved in
sels by vasculogenesis require full-length ephrinB2,ephrinB2DC protein. A hemagglutinin (HA) epitope tag was fused to
suggesting that the ephrinB2 cytoplasmic domain andthe ephrinB2DC carboxyterminus for protein detection (not shown).
A loxP-flanked (black triangles) neomycin selection marker (black reverse signaling are essential in vascular cells.
box) was used for subsequent removal by the Cre recombinase
(not shown). HindIII restriction sites (“H”), probes used for Southern
Resultshybridization, and primer sets for RT-PCR (DC, WT) are indicated.
(B) Homologous recombination was verified by Southern hybridiza-
Generation of Mutant Mice Expressingtion with ES cell genomic DNA following enzymatic restriction by
HindIII. Probe 1, corresponding to intronic sequences adjacent to Truncated EphrinB2
the 39 end of the targeted region, detected a 6.2 kb DNA fragment To study the function of the ephrinB2 cytoplasmic do-
for the wild-type allele both in untransfected (wt) and clones of main in vivo, we targeted the mouse ephrinB2 gene and
transfected ephrinB2WT (WT#1,2) or ephrinB2DC (DC#1, 2, 3) ES cells.
inserted a cDNA encoding either full-length wild-typeThe 3.1 kb DNA fragment corresponding to the targeted allele was
(ephrinB2WT) or truncated ephrinB2 (ephrinB2DC), inonly present in transfected cells.
(C) The neomycin resistance–specific probe 2 labeled a 7.8 kb HindIII
DNA fragment only in ES cell clones after homologous recombina-
tion at the gene locus.
(D) mRNA encoding the ephrinB2 cytoplasmic domain was detect- (E–G) Appearance of freshly dissected homozygous ephrinB2 mu-
able by RT-PCR (primer set WT indicated in [A]) in E9.5 wild-type tant embryos at E9.5. No morphological differences were seen be-
embryos but not in ephrinB2DC/DC homozygotes. PCR amplification tween ephrinB2WT/WT (E) and wild-type littermates (not shown). In
with an HA tag–specific antisense oligo (set DC) yielded a product contrast, ephrinB2DC/DC mutants (F) displayed growth retardation and
exclusively from ephrinB2DC RNA. Neither amplification product was enlarged hearts as previously described for ephrinB2KO/KO animals
obtained from ephrinBKO/KO embryos (not shown). (G). Scale bar in E is 400 mm in E, F, and G.
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which 66 amino acid residues of the carboxyterminus protein isoforms of about 40–45 kDa by its absence
in null embryos (Figure 2I). Likewise, epitope-taggedwere replaced by a hemagglutinin (HA) epitope tag
(Figure 1A). Using standard gene targeting technology ephrinB2DC was detectable as 2–3 isoforms with an ap-
parent molecular weight of 35–40 kDa using an anti-HA(Figures 1B and 1C), a mouse line was established
for each of the targeted cDNA insertions, ephrinB2WT antibody. The intensities of full length and truncated
ephrinB2 in ephrinB2WT/DC double heterozygous embryosand ephrinB2DC. The neo selection cassette was subse-
quently removed by crossing heterozygous mutant mice appeared to be similar excluding the possibility that the
phenotype of ephrinB2DC/DC mutants was due to poorwith a deleter-cre line. The cre allele was removed by
backcrossing to C57BL/6 wild-type animals so that mu- expression of ephrinB2DC protein (Figure 2J).
Ectopic expression of carboxyterminally truncatedtants expressed neither Cre recombinase nor neomycin
resistance. Both mutants (ephrinB2WT/WT and ephrinB2DC/DC) ephrinB2 protein had previously been shown to induce
autophosphorylation of its cognate EphA4 receptor inand ephrinB2 knockout mice (Adams et al., 1999) were
analyzed in similar mixed C57BL/6 3 129svev back- zebrafish hindbrain cells (Xu et al., 1999). We wanted to
test whether ephrinB2DC protein was also able to activategrounds to allow direct comparison. Interbreeding of
ephrinB2WT heterozygous animals yielded viable, healthy, endogenous EphB4 receptors in primary endothelial
cells. We expressed either ephrinB2WT or ephrinB2DC inand fertile homozygous offspring at Mendelian ratios
indicating that no detrimental defects were caused by HEK293 cells and obtained membrane preparations of
transfected cells to stimulate EphB4 receptors on cul-the targeting procedure and the switch to cDNA expres-
sion itself. In contrast, homozygous ephrinB2DC/DC mice tured human umbilical vein endothelial cells (HUVECs).
Similar levels of EphB4 receptor tyrosine phosphoryla-were found to be embryonic lethal at midgestation
(E10.5–E11) already exhibiting general growth retarda- tion were observed with ephrinB2WT- and ephrinB2DC-
containing membranes, whereas membranes fromtion and inflation of the pericard highly reminiscent of
the ephrinB2 knockout phenotype at E9.5 (Figures 1F mock-transfected cells did not induce EphB4 autophos-
phorylation over background levels (Figure 2K). This re-and 1G). Again, freshly dissected ephrinB2WT/WT embryos
(Figure 1E) displayed no growth retardation or develop- sult confirmed the ability of ephrinB2 to activate its re-
ceptor on adjacent cells independent of the ligandmental defects and were indistinguishable from control
ephrinB2WT/1 or wild-type littermates (not shown). cytoplasmic domain.
Expression of EphrinB2 and Its ReceptorsThe EphrinB2 Cytoplasmic Domain Is Not
Essential for Cell Surface Localization in Branchial Arches and Cranial Neural
Crest Cellsand Eph Receptor Activation
To exclude that severe defects of ephrinB2DC/DC mutants As shown in Figure 2, branchial arches are prominent
sites of ephrinB2 expression in the early mouse embryowere due to lack of expression from the knockin allele,
we investigated expression of the truncated transmem- and branchial arch morphogenesis is defective in
ephrinB2 null mutants (see below). We therefore ana-brane ligand in mouse embryos. By in situ hybridization
with an antisense RNA probe, expression of ephrinB2 lyzed in more detail the expression of ephrinB2 and its
receptors in branchial arches. By staining with EphB4-was easily detectable in forebrain, hindbrain, branchial
arches, dorsal aorta, and aortic arches of E9.5 (18–25 AP fusion protein, ephrinB2 protein was detected in the
branchial arch region already at E8.5, where it was mostsomites) wild-type animals (Figure 2A). Very similar ex-
pression patterns and levels were seen in ephrinB2WT/WT pronounced in the cleft area between arches 1 and 2,
a contact zone between surface ectoderm and foregutand ephrinB2DC/DC mutants, whereas no signal above
background levels was detected in ephrinB2 knockout endoderm (Figure 3A). Sectioning identified surface ec-
toderm as the primary source of ephrinB2 (Figure 3B).embryos (Figures 2B–2D). We used a fusion of the
aminoterminal EphB4 receptor ectodomain and alkaline Likewise, ephrinB2 mRNA could be detected by in situ
hybridization in branchial arch surface ectoderm and inphosphatase (EphB4-AP) to detect ephrinB2 protein,
which appears to be the only known ligand for this re- adjacent mesenchymal cells in E9.5 embryos (Figure
3C). Ectoderm and gut endoderm form the pocket-likeceptor (Wilkinson, 2000). Specific staining in E9.5 wild-
type embryos was most prominent in hindbrain and structure of the branchial arch that is subsequently pop-
ulated by migrating mesodermal and cranial neural crestbranchial arches (Figure 2E) and completely absent in
ephrinB2 null mutants (Figure 2H). Specific staining was cells. In 15–25 somite stage embryos, these cell popula-
tions express multiple receptors for ephrinB2. EphA4also seen in hindbrain and branchial arches of both
homozygous ephrinB2WT/WT and ephrinB2DC/DC mutants, receptor, detected by a lacZ knockin allele (Helmbacher
et al., 2000), was expressed on cells migrating to theindicating that the cDNA encoded ligand protein is avail-
able at the cell surface of the embryos where it can be second and third, but not to the first arch (Figures 3D
and 3E). Similarly, in situ hybridization analysis with anrecognized by the corresponding receptors (Figures 2F
and 2G). ephB3 antisense probe labeled cells migrating into all
three arches (Figure 3H); signals for ephB1 in the sameEphrinB2 protein can be detected in embryo lysates
by immunoblotting with an anti-ephrinB2 antibody after area were present, but much weaker (Figure 3F). In con-
trast, we failed to see expression of EphB2lacZ fusionpull down with wheat germ agglutinin (WGA), a lectin
that binds the N-acetyl-b-D-glucosamyl residues of gly- protein (Henkemeyer et al., 1996) on these cell streams
(Figure 3G). Instead, EphB2 was expressed in the trigem-cosylated cell surface proteins. Although numerous
bands of different molecular weights were recognized inal ganglion (V) and the nervus vagus (VII), which are
derived from a different neural crest cell population (Fig-by this procedure, ephrinB2 was identified as several
Cell
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Figure 2. Expression of EphrinB2 in Mutant
Embryos and EphB4 Receptor Activation
(A–D) Whole-mount in situ hybridization anal-
ysis of ephrinB2 mRNA and (E–H) staining
with EphB4-AP receptor bodies for the detec-
tion of ephrinB2 protein in (A and E) wild-type,
(B and F) ephrinB2WT/WT, (C and G) ephrin-
B2DC/DC, and (D and H) ephrinB2KO/KO. The frontal
part of E9.5 embryos (20–25 somites) are
shown. An ephrinB2 antisense RNA probe spe-
cifically labeled hindbrain, branchial arches,
aortic arch, and dorsal aorta (arrowheads) in
wild-type control embryos (A). Similar pat-
terns and intensities of signals were obtained
for ephrinB2WT/WT and ephrinB2DC/DC homozy-
gotes (B and C), but not for ephrinB2 knock-
out embryos (D). Alkaline phosphatase activ-
ity derived from the EphB4-AP fusion protein
was detected in hindbrain and branchial
arches of wild-type (E), ephrinB2WT/WT (F), and
ephrinB2DC/DC (G), but not in ephrinB2KO/KO em-
bryos (H). The complete lack of binding of
EphB4-AP in ephrinB2 knockout embryos
indicates the specificity of EphB4 toward
ephrinB2.
(I) Glycosylated cell surface proteins from
E9.5 wild-type or homozygous ephrinB2KO/KO
embryos were enriched by pull down with
wheat germ agglutinin (WGA). Endogenous
ephrinB2 ligand (B2, 40–45 kDa) was de-
tected by Western blotting with an antibody
directed against the extracellular domain of
the mouse protein. Note absence of specific
bands in knockout embryos (KO/KO).
(J) Epitope-tagged ephrinB2DC (B2DC, 35–40
kDa) expressed in E10.5 mutant animals was
identified by WGA pull down and immu-
noblotting with an anti-HA antibody. The sig-
nal was absent in ephrinB2WT heterozygotes
(WT/1). EphrinB2DC protein (doublet or triplet
bands) was also recognized by anti-ephrinB2
antibody. Expression levels appeared similar
to ephrinB2WT full-length protein (B2WT) in
double heterozygous ephrinB2WT/DC mutants
(WT/DC), though somewhat reduced in com-
parison to untargeted wild-type animals (not
shown). Additional bands (.48 kDa and ,35
kDa) were also seen in lysates from ephrinB2
KOs and thus were considered nonspecific.
(K) Endogenous EphB4 receptor expressed
by primary human umbilical vein endothelial
cells (HUVEC) was either left unstimulated, or
stimulated with membrane extracts from 293
cells transfected with either empty vector
(mock) or ephrinB2WT and ephrinB2DC expres-
sion constructs. Tyrosine phosphorylation
was analyzed by Western blotting of immunoprecipitated EphB4 protein. Receptor activation by antibody-clustered ephrinB2-Fc (0.2 and 1
mg/ml) are shown as positive controls. A shorter exposure is shown. After stripping of the blot, levels of EphB4 receptor were immunodetected
with aEphB4 antibody. Scale bar in (H) is 160 mm in (A)–(H).
ure 3G). These results indicated that at least three recep- derm around its interface with foregut endoderm (Figure
3K). These ephrinB2-positive regions appeared to betors, EphA4, EphB1, and EphB3, are expressed at the
right time in cell populations, which migrate along a path avoided by cranial neural crest cells (Figure 3L). Indeed,
sections of embryos stained by whole-mount in situoutlined by ephrinB2-expressing cells.
In the dorsal neural tube, prominent ephrinB2 expres- hybridization confirmed that ephrinB2 and crabp1 ex-
pression were mutually exclusive (Figures 3M and 3N).sion was detected below emerging and migrating neural
crest cells, identified by expression of cellular-retinoic-
acid binding-protein 1 (crabp1; Maden et al., 1992), a Branchial Arch Defects in ephrinB2 Null,
but Not ephrinB2DC/DC Mutantsmarker for multiple streams of cranial neural crest cells
(Figures 3I and 3J). As described above, ephrinB2 pro- The prominent expression of ephrinB2 in branchial
arches and its receptors on migrating cells in the cranialtein was also prominently seen in cleft surface ecto-
Deletion of the EphrinB Carboxyterminus
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Figure 3. Expression of EphrinB2 and Its
Cognate Eph Receptors in Branchial Arches
and the Hindbrain Region
Whole-mount EphB4-AP staining (A, B, and
K) or in situ hybridization analysis of wild-
type embryos with (C, I, and M) ephrinB2, (F)
EphB1, and (H) EphB3 antisense RNA probes.
Embryonic stages shown are E8.5 (10–12 so-
mites; A and B) or E9.5 (20–25 somites; C, F,
and H–N). b-galactosidase stainings of het-
erozygous (D and E) EphA4lacZ and (G) Eph-
B2lacZ knockins at E9.0 or E9.5 are shown.
(A and B) E8.5, ephrinB2 expression is
most prominent in surface ectoderm of the
branchial pouch region. (C) Expression per-
sists in E9.5 surface ectoderm and adjacent
mesenchyme (arrowheads) of first (b1) and
second branchial arch (b2), as seen in sagittal
sections of whole-mount stained embryos.
EphA4lacZ is a marker for cells migrating into
the second and third arch of E9.0 (D) and E9.5
(E) embryos. Note the absence of label in the
surface ectoderm of the second arch in E (see
insert). In contrast, only low levels of EphB1
mRNA (F) and absence of EphB2lacZ protein
(G) was noted on cells migrating into the
arches. Expression of b-galactosidase under
control of the EphB2 promoter was, however,
seen in other neural crest–derived tissues
such as the trigeminal ganglion (tg) and in gut
endoderm forming the inner lining of pharyn-
geal arches (arrowheads in G). (H) EphB3-
expressing cells were found to populate all
three arches and the periphery of the trigemi-
nal ganglion (tg). In transverse sections of
stained embryos, ephrinB2 expression was
observed in the dorsal neural tube (I) below streams of crabp1-positive neural crest cells (J). Complementary expression domains for ephrinB2
(K) and crabp1 (L) were seen in the branchial arch region. Cleft between b1 and b2 has been outlined in (L). As seen in sections through the
branchial arch region (cleft between b1 and b2 is shown), crabp1-expressing cranial neural crest cells (N) were absent in ephrinB2-expressing
tissues (M, arrows in K–N).
Scale bar in (N) is 90 mm in (A), 30 mm in (B), 80 mm in (C), 120 mm in (D), 160 mm in (E)–(H) and (K)–(L), 60 mm in the insert of (E), and 40 mm
in (I)–(J) and (M)–(N).
region prompted us to analyze this structure in mu- outs, which exhibited only mild hypoplasia of hyoid
arches (Figure 4H and data not shown). Furthermore,tant animals. In freshly dissected E9.5 (20–25 pairs of
somites) wild-type or ephrinB2WT/WT embryos, three the absence of second aortic arches was confirmed in
sagittal sections of embryos lacking ephrinB2 (Figurebranchial arches were easily visible (Figures 4A and 4B).
Interestingly, in homozygous ephrinB2 null mutants, the 4L). Vessel lumina were clearly visible in sectioned
ephrinB2DC/DC and control embryos, consistent with thesecond (hyoid) arch was either absent or reduced in size
(34% and 55%, respectively; n 5 58; Figure 4D). This results of the anti-PECAM1 staining (Figures 4I–4K).
Thus, the truncated ephrinB2DC protein rescued thedefect was most prominent in the central part and less
pronounced in the distal and proximal regions of the branchial and aortic arch defects seen in ephrinB2 null
mutants.arch. In contrast, normal formation of branchial arches
was observed in 92% of ephrinB2DC/DC homozygotes (8%
reduced in size; n 5 61), despite their general growth Early Branchial Arch and Neural Crest
Formation in ephrinB2 Mutantsretardation, which was very similar to ephrinB2 knock-
outs (Figure 4C). At this stage of development, pairwise We next analyzed the time course and attempted to
identify possible causes for cranial defects in ephrinB2sets of blood vessels (aortic arches) have normally
formed inside each pair of the three branchial arches to null mutants. At E8.5, branchial arch morphology of
ephrinB2KO/KO mutants was devoid of obvious defectsdirect the blood flow from the heart to the aorta. We used
whole-mount immunohistochemistry with anti-PECAM1 and appeared similar to control or ephrinB2DC/DC em-
bryos. Ecto-/endodermal contact zones in the pouchantibodies to visualize the endothelial lining of aortic
arches and other blood vessels. Stained vessels were region between the first and second arch were clearly
visible as well as first arch arteries (Figures 5A–5C).clearly visible in the hyoid arches of control (wild type
or ephrinB2WT/WT) and ephrinB2DC/DC embryos, but com- Thus, loss of ephrinB2 seemed not to interfere with the
earliest steps of branchial arch development. In the em-pletely absent in the vast majority of ephrinB2 knockouts
(91%; n 5 23; Figures 4E–4H). Similar agenesis of aortic bryonic hindbrain, Eph/ephrin molecules are expressed
in rhombomere-specific patterns and appear to be in-arches occurred in the proportion of ephrinB2 knock-
Cell
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Figure 4. Hyoid Arch Defects in the ephrinB2 Knockout Are Rescued in ephrinB2DC/DC Mutants
(A–D) Appearance of branchial arches in freshly dissected (A) wild-type, (B) ephrinB2WT/WT, (C) ephrinB2DC/DC, or (D) ephrinB2KO/KO embryos.
Arches (1–3) were outlined by a dotted line. Note the reduction of the second branchial (hyoid) arch (arrow in D) in ephrinB2 knockout, whereas
normally developed arches can be seen in ephrinB2DC/DC or wild-type control animals.
(E–H) The endothelial lining of blood vessels was visualized by whole-mount immunohistochemistry with aPECAM1 (aCD31) antibody. PECAM1-
positive second aortic arches were seen in wild-type, ephrinB2WT/WT and ephrinB2DC/DC embryos (arrows in E, F, and G), but were absent in
ephrinB2 null mutants (H).
(I–L) Sagittal sections were stained by hematoxylin and eosin. Note the absence of a vessel lumen in the hyoid arch of ephrinB2KO/KO animals
(arrow in L), in contrast to matching sections through wild-type (I), ephrinB2WT/WT (J), or ephrinB2DC/DC (K) heads. Dorsal aorta (ao) can be seen
in embryos of all four genotypes. Scale bar in (L) is 160 mm in (A)–(L).
volved in cell sorting and boundary formation (reviewed 5J), was maintained even in ephrinB2 null animals (Fig-
ure 5L), suggesting that the gene was not critically re-in Wilkinson, 2000). As defects in the patterning of rhom-
bomeres could well affect cranial crest migration and quired for early crest migration.
branchial arch morphogenesis, we analyzed the hind-
brain region of ephrinB2 mutants by in situ hybridization Carboxyterminally Truncated EphrinB2 Is
Sufficient for Guidance of Cranial Neuralwith an antisense krox20 probe (Sham et al., 1993).
Krox20 labeled rhombomeres 3 and 5 and an r5-derived Crest Cells
Since cranial neural crest cells significantly contribute tostream of crest cells in ephrinB2KO/KO, ephrinB2DC/DC, and
control animals, indicating that this structure developed mesenchyme and perhaps endothelium in the branchial
arches, we followed the pathway of migrating crest cellsnormally in spite of partial or complete loss of ephrinB2
function (Figures 5D–5F). The homeobox gene hoxb1 is populating this structure by whole-mount in situ hybrid-
ization with a crabp1 antisense probe. Specific staininga marker for the fourth rhombomere and streams of
crest cells emerging at the r4 neural folds (Studer et in wild-type embryos at E9.5 (20–25 somites) could be
seen in streams of cells migrating ventrally into theal., 1998). This characteristic expression pattern was
detectable in all ephrinB2 mutant lines (Figures 5H and arches as well as other target regions (Figure 6A). We
found this late migration of crabp1-positive cells to be5I). Expression levels in both rhombomere 4 and r4-
derived crest cells, however, were reduced in ephrinB2 severely disrupted in ephrinB2 null mutants. Only a few
labeled cells were visible in the distal and proximal areasnull animals (Figure 5I). EphrinB2DC was sufficient to
largely, but not fully, restore hoxb1 expression levels and the signal was even weaker in the central part of
the second arch (Figure 6C). Cranial crest cells were nocompared to ephrinB2WT/WT (Figures 5G and 5H) or wild-
type controls (data not shown). Similar results were ob- longer migrating in a well defined stream, were scat-
tered, and invading adjacent areas that were normallytained by staining for crabp1: lower levels of crabp1
expression were found in the cranial region of ephrin- devoid of signal in control embryos (arrowheads in Fig-
ures 6A–6C). Expression of ephrinB2 ligand lacking itsB2KO/KO mutants, and this reduction was most prominent
for r4-derived crest (Figure 5L). Like hoxb1 expression, cytoplasmic domain was, however, sufficient to largely
restore the normal pattern of crest migration into thecrabp1 levels were largely restored in ephrinB2DC/DC em-
bryos (Figure 5K). However, the principle pattern of hyoid arch of ephrinB2DC/DC embryos (Figure 6B).
In transverse sections through the hindbrain regioncrabp1-positive cell streams emerging from rhombo-
mere 4, as seen in ephrinB2WT/WT control animals (Figure of whole-mount stained wild-type embryos, the stream
Deletion of the EphrinB Carboxyterminus
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Figure 6. Cranial Neural Crest Cell Migration in ephrinB2 Knockin
Mutants
(A–I) Hindbrain and branchial arch region of E9.5 embryos stained
by whole-mount in situ hybridization with an antisense crabp1 probe
that labels neural crest cells. Images of whole mounts (A–C) andFigure 5. Early Branchial Arch and Hindbrain Morphology in
transverse sections (D–I) as indicated by dotted lines in (A) areephrinB2 Mutants
shown. A stream of crabp1-positive cranial crest cells originated at(A–C) Hematoxylin and eosin stained transverse sections through
the dorsal neural tube and migrated into the second branchial archfirst (b1) and second branchial arch (b2) of E8.5 ephrinB2 mutants.
(arrow) of (A) wild-type or (B) ephrinB2DC/DC animals. In ephrinB2Normal morphology was seen in ephrinB2WT/WT (A), ephrinB2DC/DC (B),
knockouts, this pattern was severely disrupted and only a few la-and ephrinB2KO/KO (C) embryos. (D–F) Whole-mount in situ hybridiza-
beled cells were found in the hyoid arch (C). Instead, crabp1-positivetion of E9.5 embryos with a krox20 antisense cRNA probe. Similar
cells appeared to be scattered and invaded regions which werestaining patterns of rhombomeres r3 and r5 and crest cells emerging
devoid of signal in wild-type and ephrinB2DC/DC embryos (arrowheadsfrom r5 (arrowheads) were seen in all samples (D, E, and F). Rhom-
in [A]–[C]). A sharp stripe (indicated by arrowheads in [D]–[F]) ofbomere 4 and r4-derived crest cells expressing hoxb1 were visual-
crabp1-positive crest cells was visible in sections of (D) wild-typeized by in situ hybridization in ephrinB2WT/WT control animals (G).
controls and (E) ephrinB2DC/DC homozygotes. Loss of ephrinB2Similar patterns, but reduced expression levels were seen in
caused this stripe to appear wider and more diffuse (F). Barely anyephrinB2DC/DC (H) and most prominently in ephrinB2KO/KO (I) mutants.
labeled cells can be seen in transverse sections through the middleLikewise, crabp1 staining of crest cells emerging from rhombomere
of the hypoplastic second arch (I), in contrast to (G) wild-type and4 was significantly weaker in ephrinB2 null mutants (L) compared
(H) ephrinB2DC/DC arches.to homozygotes expressing full-length ephrinB2 (J). Again, expres-
(J–L) Whole-mount in situ hybridization analysis with an erbB3 anti-sion levels were largely, but not entirely restored in ephrinB2DC/DC
sense probe labeling neural crest cells that give rise to Schwannmutants (K).
cells in the trigeminal ganglion and facial nerve (arrows). (J) Wild-Scale bar in (L) is 50 mm in (A)–(C) and 100 mm in (D)–(L).
type, (K) ephrinB2DC/DC, and (L) ephrinB2KO/KO embryos displayed very
similar staining patterns, suggesting normal migration of this cell
population. Scale bar in (L) is 240 mm in (A)–(C) and (J)–(L) and 40
mm in (D)–(I).of crabp1-positive crest cells migrating from the dorsal
neural tube was clearly separated from adjacent tis-
sue (Figure 6D). A similar pattern was observed in
ephrinB2DC/DC homozygotes, although the packing of 6I). Corresponding sections of ephrinB2DC/DC or wild-type
embryos contained numerous crabp1-positive crestcells seemed to be not quite as compact as in control
embryos (Figure 6E). In animals deficient for ephrinB2, cells in close proximity of surface ectoderm (Figures
6G and 6H). Whole-mount in situ hybridization with anthe stripe containing labeled cells appeared much wider.
The transition between labeled and unlabeled tissues antisense RNA probe recognizing erbB3, a marker for
a different population of neural crest cells, giving risewas very diffuse (Figure 6F), in contrast to the sharp
boundary seen in wild-type littermates. Likewise, in to Schwann cells of ganglia and nerves in the hindbrain
region, gave similar results for ephrinB2DC/DC, ephrinB2ephrinB2 knockouts, barely any blue cells reached the
central region of the second branchial arch, which ap- null, and control embryos (Figures 6J–6L). Blue staining
was seen in trigeminal (V) and facial (VII) ganglia andpeared very hypoplastic in transverse sections (Figure
Cell
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Figure 7. Blood Vessel Defects in ephrin-
B2KO/KO and ephrinB2DC/DC Embryos
(A–L) Embryonic vasculature in E9.5 embryos
was visualized by whole-mount immunohis-
tochemistry with aPECAM-1 antibody. Hier-
archically organized blood vessels of dif-
ferent diameters can be seen in heads of
wild-type (A) or ephrinB2WT/WT control embryos
(B), whereas in ephrinB2DC/DC (C) and ephrin-
B2KO/KO mutants (D) the vasculature remained
at the primitive capillary plexus stage. PECAM-
1-stained dorsal aorta, aortic arches, and an-
terior cardinal vein (arrows in [E]–[H]) are nor-
mally seen in the anterior trunk region (E and
F). Note defective vasculogenesis of the ante-
rior cardinal vein in (G) ephrinB2DC/DC and (H)
ephrinB2 null animals. Intersomitic vessels
growing in the dorsal direction (right) were not
sprouting into somitic tissue of E9.5 control
embryos (I and J), but disorganization of
these vessels was caused by truncation (K)
or loss (L) of ephrinB2. Aberrant sprouts are
indicated by arrows. Scale bar in (L) is 260
mm in (A)–(D), 320 mm in (E)–(H) and 140 mm
in (I)–(L).
nerves, demonstrating that the defects in ephrinB2 null 7L) (Adams et al., 1999). These findings provide genetic
proof that ephrinB2 requires a cytoplasmic domain tomutants were specific and did not cause a general dis-
ruption of patterning and migration in the hindbrain mediate vascular morphogenesis during mouse em-
bryogenesis. They further suggest that ephrinB2 reverseregion.
signaling or other functions mediated by the cyto-
plasmic domain in addition to EphB receptor forwardThe EphrinB2 Cytoplasmic Domain Is Required
signaling may be important for this process.for Vascular Morphogenesis
EphrinB2 and its cognate EphB2, EphB3, and EphB4
receptors were previously shown to regulate angiogenic In Vitro Endothelial Sprouting Is Induced
by EphB-Fc, Suggestive of EphrinBremodeling in the mouse embryo. At E9.5, heads of
wild-type or ephrinB2WT/WT embryos contained a highly Reverse Signaling
Using an in vitro sprouting assay as a correlate of indeveloped, hierarchically organized vascular system
with large diameter blood vessels branching into smaller vivo sprouting angiogenesis, we had previously demon-
strated that ephrinB1 and ephrinB2 ligands had stimula-vessels (Figures 7A and 7B). Lack of ephrinB2 resulted
in the arrest at the primitive capillary plexus stage (Figure tory influences on capillary sprouting of adrenal cortex–
derived microvascular endothelial (ACE) cells (Adams7D). Expression of truncated ephrinB2DC protein did not
restore angiogenic remodeling (Figure 7C). Similar de- et al., 1999). Having observed an in vivo requirement for
the ephrinB2 cytoplasmic domain, we reasoned thatfects were found for the yolk sac vasculature of
ephrinB2DC/DC homozygotes (data not shown). In the stimulating endogenous ephrinB ligands with EphB sol-
uble ectodomains might induce in vitro sprouting. Puri-trunk region of the embryo, major vessel primordia, such
as dorsal aorta and cardinal veins, are formed by vascu- fied EphB3-Fc and EphB4-Fc fusion proteins induced a
significant, dose-dependent increase in the number oflogenesis. We had previously observed defects in the
formation of cardinal veins in ephrinB2 null mutants (Fig- sprouts with a length exceeding the diameter of the
bead (Figure 8). In contrast, EphB2-Fc (this study) andure 7H) (Adams et al., 1999). As shown in Figure 7G,
anterior cardinal veins did not form in ephrinB2DC/DC em- EphB1-Fc (Adams et al., 1999) were not effective in this
assay, suggesting a certain degree of functional speci-bryos. Endothelial cells were arranged in a loose, irregu-
lar network and did not form a tubular structure, resem- ficity of the response. Differences in sprout inducing
activity may be due to different binding kinetics. Highestbling the phenotype of ephrinB2 null mutants (Figure
7H). Intersomitic vessels extend from dorsal aorta and affinities toward ephrinB2 were measured with EphB3
and EphB4 receptors, compared to EphB1 and EphB2cardinal vein in a dorsal direction in a segmented pat-
tern. In E9.5 wild-type or ephrinB2WT/WT embryos, these (for review, see Flanagan and Vanderhaeghen, 1998).
These results indicate that in vitro endothelial sproutingvessels were found to respect somitic boundaries by
not forming endothelial sprouts penetrating into somites can be mediated by ephrinB stimulation and presumably
reverse signaling and provide strong support for the(Figures 7I and 7J). In contrast, numerous aberrant
branches and sprouts invaded somitic tissue in both concept that this process is required for vascular mor-
phogenesis in vivo.ephrinB2DC/DC and ephrinB2KO/KO mutants (Figures 7K and
Deletion of the EphrinB Carboxyterminus
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ing an important regulator of vascular development
(Wang et al., 1998; Adams et al., 1999), ephrinB2 is
essential for branchial arch morphogenesis. We further
demonstrate that in order to mediate angiogenic remod-
eling, ephrinB2 requires its highly conserved cyto-
plasmic domain. In vitro, angiogenic sprouting can be
induced by soluble EphB-Fc receptor bodies, sug-
gesting that ephrinB can indeed have receptor-like sig-
naling properties. Together, these results emphasize the
importance of the cytoplasmic domain of transmembrane
ephrins, presumably to mediate reverse signaling in vas-
cular morphogenesis. In contrast, carboxyterminally trun-
cated ephrinB2 rescues the migration defect of branchial
neural crest cells, suggesting that forward signaling via
EphB receptors in crest cells is sufficient for this pro-
Figure 8. EphrinB-Mediated Angiogenic Sprouting In Vitro
cess. Finally, we show that expression of carboxy-
Adrenal-cortex-derived microvascular endothelial cells (ACE) were
terminally truncated ephrinB2 results in downregulationcultured on beads in three-dimensional fibrin gels. Following 2 days
of Ang1 expression in mesenchymal cells, implying thatof incubation, endothelial sprouts exceeding the diameter of the
reverse ephrin or bidirectional ephrin/Eph signaling isbead were quantified and normalized relative to basal sprouting
activity in the absence of angiogenic factors (Control). Endothelial required for proper communication between endothelial
sprouting was induced by incorporation of dimeric EphB3-Fc or and mesenchymal cells.
EphB4-Fc, but not EphB2-Fc fusion proteins (0.22 and 1 mg/ml) into A potential caveat is raised by the discovery that, in
the fibrin matrix. Saturating amounts (0.67 mg/ml) of recombinant solution, higher-order clustering of ephrins is requiredangiopoietin-1 (Ang1*) were used as positive control.
for full activation of Eph receptors. Because clustering
of transmembrane ephrins may be mediated by the cyto-
Reduced Tie2 and Angiopoietin-1 Expression plasmic domain through interaction with intracellular
in ephrinB2 Mutants proteins, it is possible that the ephrinB2DC mutant may
We next introduced a tie2-lacZ reporter transgene not be fully functional in triggering Eph receptor forward
(Schlaeger et al., 1997) into our ephrinB2 allelic series signaling. Several observations make this interpretation
to use endothelial-specific expression of b-galactosi- rather unlikely. Ephrins and Eph receptors restrict cell
dase as an independent marker for vascular morpho- intermingling across hindbrain segment boundaries. It
genesis. As observed by anti-PECAM1 immunohisto- was shown that ectopically expressed truncated ephrins
chemistry, both ephrinB2KO/KO and ephrinBDC/DC embryos are sufficient for cell sorting toward rhombomere bound-
showed b-galactosidase positive endothelial cells ar- aries (Xu et al., 1999). Truncated ephrinB2 was also
rested at the capillary plexus stage (Figures 9B and 9C). sufficient to restrict communication between cells via
Surprisingly, the expression of b-galactosidase from a gap junctions and to restrict cell intermingling in a zebra-
single allele of the tie2-lacZ transgene was greatly re- fish animal cap assay (Mellitzer et al., 1999). In our sys-
duced in both mutants compared to wild-type (Figure tem, truncated ephrinB2DC rescues branchial arch mor-
9A) or ephrinB2WT/WT control animals (data not shown). phogenesis, but not angiogenesis. If lack of Eph
Reduced expression of the endogenous tie2 gene in receptor activation due to insufficient ephrin clustering
ephrinB2KO/KO and ephrinBDC/DC embryos was confirmed caused the angiogenesis defect, one would have to ar-
by whole-mount immunohistochemistry using anti-Tie2 gue that the mechanism of ephrin clustering is different
antibodies (Figures 9E and 9F). In contrast, expression of in branchial arch ectoderm/mesenchyme and endothe-
vascular endothelial growth factor receptor-2 (VEGFR2) lial cells. However, there is currently no evidence in favor
was unaffected in ephrinB2 mutants (Figures 9H and of such differential mechanisms. Previous work has also
9I). We next determined the levels of Tie2 mRNA by demonstrated that ephrinB1, a homolog of ephrinB2,
semiquantitative RT-PCR analysis using GAPDH as ref- can be located in sphingolipid/cholesterol-enriched raft
erence. It was confirmed that the levels of VEGFR2 membrane microdomains, which was not the case for
mRNA were unchanged in both ephrinB2 mutants. In a carboxyterminally truncated version of the ligand
contrast, the levels of tie2 mRNA and its cognate ligand (Bru¨ckner et al., 1999). Potential alterations in plasma
angiopoietin-1 (Ang1) were significantly reduced relative membrane microdomain localization are apparently not
to VEGFR2 mRNA (Figures 9J and 9K) or VEGFR1, VEGF, affecting gap junction formation and reconstituted bidi-
Tie1, Ang2, VE-Cadherin, and PECAM-1 mRNAs (data rectional signaling in a zebrafish animal cap assay (Mel-
not shown). Ang1 is normally produced by support cells, litzer et al., 1999) or guidance of cranial crest cells in vivo
while Tie2 receptors are expressed by endothelial cells. (this study). Therefore, truncated ephrinB2DC appears
The fact that Ang1 expression is reduced in ephrinB2KO/KO capable of triggering Eph receptor forward signaling,
and ephrinBDC/DC mutants suggests a requirement for but incapable of triggering reverse signaling, via its cyto-
ephrin/Eph bidirectional signaling in endothelial/mesen- plasmic tail. We therefore demonstrate distinct require-
chymal cell interactions. ments for morphogenetic functions mediated by the
ephrinB2 extracellular and cytoplasmic domains, re-
Discussion spectively.
Previous studies have addressed the role of ephrin/
In this study, we present genetic evidence that ephrinB2 Eph molecules in guidance of neural crest cells of verte-
brate embryos. Several EphA and EphB receptors wereexerts a dual role in mouse development. Besides be-
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shown to be expressed on cranial neural crest (CNC)
cells populating third and fourth branchial arches in Xe-
nopus laevis. Contrary to the mouse, ephrinB2 was found
in adjacent second arch neural crest and mesoderm
(Smith et al., 1997; Helbling et al., 2000). RNA injection
and overexpression of ephrinB2 or truncated EphA4 or
EphB1 receptors induced scattering of CNC cells into
adjacent regions in Xenopus embryos (Smith et al.,
1997). The phenotype was very similar to ephrinB2 null
mutant mice described in this study, in spite of species-
specific differences in expression patterns. In the em-
bryonic trunk region, EphB receptor-expressing crest
cells in vitro avoided substrate stripes containing re-
combinant ephrinB1- or ephrinB2-Fc protein (Krull et
al., 1997; Wang and Anderson, 1997). A repulsive mecha-
nism, similar to axonal growth cone pathfinding, leading
to the characteristic segmental rostrocaudal pattern of
migrating crest was suggested by both studies. Similari-
ties in the expression of Eph receptors, found on CNC
cells, and ephrinB2, in branchial arches, make it attrac-
tive to postulate that a repulsive mechanism might also
be operating for crest guidance in embryonic heads.
Our analysis of hindbrain patterning and CNC morpho-
genesis in ephrinB2 mutants revealed downregulation
of markers for r4-derived crest cells. In contrast, no
alterations were seen for krox20-positive cells emerging
from rhombomere 5. What might be the function of
ephrinB2 in this early step of cranial crest morphogene-
sis and how can it be specific for one CNC subpopulation
but not for another? Neural crest cells delaminate from
the neuroectoderm at the epidermal–neural plate inter-
face before they migrate toward their target sites. Solu-
ble factors, such as Bmp2, secreted by the surface ecto-
derm, are required for the induction of crest cells and
maintenance of their cell fate (Kanzler et al., 2000). Re-
markably, blocking of Bmp2/4 function by transgenic
noggin expression or inactivation of the Bmp2 gene
caused defects in formation and/or migration of crabp1-
positive cranial crest cells (Kanzler et al. 2000), a pheno-
type that resembles defects seen in ephrinB2 null mu-
tants. Thus, ephrinB2, expressed by the dorsal neural
ectoderm, might be involved in cranial neural crest de-
lamination and migration out of the neuroepithelium,
presumably by providing a repulsive signal. ExpressionFigure 9. Reduced Expression of Tie2 and Angiopoietin-1 in
ephrinB2 Mutants of ephrinB2 in the E8.5/E9.5 hindbrain is specific for
(A–C) Expression of b-galactosidase under control of the Tie2 pro- even-numbered rhombomeres, which might explain why
moter (Tie2-lacZ) gave a strong endothelial cell-specific staining in r4- but not r5-derived crest cells are affected. Levels of
E9.5 wild-type embryos (A), but was reduced in (B) ephrinB2DC/DC or hoxb1 and crabp1 signals and CNC development appear
(C) ephrinB2KO/KO mutants processed in parallel. Normal lacZ reporter to be largely restored in ephrinBDC/DC mutants, indicating
expression was seen in part of the cardinal vein close to the sinus
that the ephrinB2 cytoplasmic domain is not criticallyvenosus (arrows in [B] and [C]).
required for this process. The slight reduction of marker(D–F) Whole-mount immunohistochemistry with aTie2 antibody.
Vascular staining in E9.5 (E) ephrinB2DC/DC or (F) ephrinB2KO/KO mu- expression in ephrinBDC/DC mutants might indicate a mi-
tants was reduced compared to control littermates (D). Note Tie2 nor contribution of the carboxyterminal domain or sim-
staining close to the sinus venous (arrows in [E] and [F]) resembling ply result from the general growth retardation caused
lacZ results. In contrast, similar staining levels were obtained with by vascular defects.
aVEGFR2 antibody for (G) wild-type, (H) ephrinB2DC/DC, and (I)
Which receptors are candidates for mediating theephrinB2 knockout embryos. (J) Ethidium bromide–stained amplifi-
ephrinB2 signal in neural crest cells? EphA4 null mutantscation products of semiquantitative RT-PCR with Tie2-, Ang1-,
VEGFR2-, and GAPDH-specific primer pairs are shown. Different displayed defects in guidance of motor nerves and for-
dilutions of single-stranded cDNA (1:1, 1:5, and 1:25, see Supple-
mental Data indicated in the Experimental Procedures) prepared
from E9.5 wild-type, ephrinB2DC/DC, or ephrinB2KO/KO embryos (n 5 7
for each genotype) were used. Levels of Tie2 and Ang1 mRNA were and normalized for GAPDH levels. No significant alteration of
reduced in ephrinB2 mutants. (K) Relative intensity levels of SYBR VEGFR2-specific product was seen. Scale bar in (I) is 400 mm in
green stained PCR products were measured in a phosphoimager (A)–(I).
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mation of the corticospinal tract (reviewed in Wilkinson, and its receptor, Tie2 (Dumont et al., 1994) resulted in
2000; see also Helmbacher et al., 2000; Kullander et al., midgestational lethality with similar vascular pheno-
2001), but had no overt phenotype affecting migration types. These phenotypes may be the result of disrupted
of neural crest cells or development of crest-derived cell–cell communication in the vascular system by differ-
tissues. Likewise, ephB2 and ephB3 null animals regu- ent, independent defects. Alternatively, these molecules
late brain commissure formation (Henkemeyer et al., may represent parts of the same signaling cascade.
1996; Orioli et al., 1996), but not crest cell guidance Indeed, reduced Ang-1 mRNA levels were reported for
(Wang and Anderson, 1997). The penetrance of commis- COUP-TFII mutant animals, suggesting a direct or indi-
sure agenesis was increased and additional defects rect connection between the transcription factor COUP-
were observed in ephB2/ephB3 double mutants, indi- TFII and the soluble ligand Ang-1 (Pereira et al., 1999).
cating functional redundancy between the two receptors In the present study, the expression of both Ang-1 and
(Orioli et al., 1996; Adams et al., 1999). Loss of EphB4 Tie2 were specifically reduced in ephrinB2 mutant ani-
resulted in vascular malformations highly reminiscent of mals, whereas numerous other vascular markers were
ephrinB2 mutants (Gerety et al., 1999). Based on staining not significantly altered. No reduction of Tie2 expression
with a lacZ reporter, EphB4 is not expressed in hindbrain was found in VE-Cadherin null animals (Carmeliet et al.,
or branchial arches (Gerety et al., 1999). Thus, it appears 1999), indicating that its downregulation is not a general
that redundant activity of multiple Eph receptors, includ- result of vascular malformation. It therefore is conceiv-
ing EphA4, EphB1, and EphB3, on cranial crest cells able that the phenotypic similarities of ephrinB2/ephB4
might mediate ephrinB2-dependent guidance. and ang-1/tie2 mutants are a consequence of transcrip-
The cytoplasmic domain of ephrinB, i.e., reverse sig- tional downregulation. Since endothelial cells coexpress
naling, appears to be important for the communication ephrin/Eph molecules and Tie2, expression of Tie2
between endothelial/periendothelial cells, but not be- might be under control of ephrinB2 reverse or bidirec-
tween branchial arch ectoderm/mesenchyme and neu- tional signaling. Mesenchymal cells in the proximity of
ral crest cells. The reason for this difference is currently blood vessels and capillaries are the site of Ang-1 ex-
unknown. Angiogenic remodeling is a complex process pression, which might be controlled by ephrinB2 interac-
which requires endothelial cells to de-adhere from one tion with Eph receptors present on mesenchymal cells.
another and from the substratum, to migrate, divide, Alternatively, an indirect mechanism, e.g., via a soluble
and form tubular structures. Endothelial cells coexpress factor secreted by endothelial cells that acts on mesen-
certain ephrin ligands and Eph receptors, which might chyme, appears equally feasible. Regardless of these
impact on many of the cellular responses during angio- different mechanisms, downregulation of the Ang1/Tie2
genic remodeling. The arterial–venous interface ap- system may be the primary cause for the observed vas-
pears to be a prominent site of ephrin/Eph interaction, cular defects in ephrinB2 mutants. In addition, the activ-
since ephrinB2 and EphB4 molecules are predominantly ity of both ephrinB and EphB molecules in sprouting
expressed on arteries and veins, respectively, and assays in vitro suggests direct roles in vascular remodel-
ephrinB2 and ephB4 mutant mice display similar vas- ing independent of the Ang1/Tie2 system.
cular defects. The apparent mutual interdependence
of their interaction has thus far precluded discrimina- Experimental Procedures
tion between uni- and bidirectional signaling between
ephrinB2 and EphB4. Further insight is now provided by Please refer to supplementary online information for details (http://
www.cell.com/cgi/content/full/104/1/57/DC1).our study, indicating that the ephrinB2 carboxyterminal
domain and its interaction with putative cytoplasmic
Generation of Mutant Miceproteins is indispensable for angiogenic remodeling.
The generation of a replacement-type targeting vector for ephrinB2Our study, however, does not demonstrate a require-
was described previously (Adams et al., 1999). Here, cDNAs encod-ment for EphB4 kinase activity, i.e., forward signaling,
ing either mouse wild-type (ephrinB2wt) or C terminally truncatedin the vascular system. A reciprocal genetic approach,
ephrinB2 (ephrinB2DC, amino acid residues 1–267, corresponding to
the generation of mutant mice expressing a kinase-dead peptide sequence MARS...HTTT) were fused in frame to exon1. For
EphB4 receptor, will allow that question to be ad- protein detection, a hemagglutinin (HA) epitope tag was added at
dressed. the ephrinB2DC carboxyterminus (...HTTT/MYPYDVPDYASL*).
Evidence for simultaneous signal transduction both
downstream of EphB4 and ephrinB2 came from in vitro RT-PCR Analysis
Total RNA was isolated from E9.5 mutant and control embryos usingdata. Either activation of EphB receptors by ephrinB-
TRIZOL reagent (GibcoBRL) according to the manufacturer’s in-Fc fusion proteins (Adams et al., 1999) or activation
structions, digested with DNAse, and subjected to reverse transcrip-of ephrinB ligands by EphB3-Fc or EphB4-Fc fusion
tion. Single-stranded cDNA was used for PCR amplification ac-
proteins is sufficient to induce endothelial sprouting in cording to standard protocols to detect expression of endogenous
vitro (this study). Thus, both means of stimulation should ephrinB2 or ephrinB2wt and ephrinB2DC mRNAs. For semiquantitative
occur in parallel between endothelial cells coexpressing RT-PCR analysis, 0.5 ml of reverse transcription reaction was either
ligands and receptors. What might be the precise role used directly or in 1:5, 1:25, 1:50, or 1:100 dilution for amplification
(33 cycles) with gene-specific primers. After separation in 1.5%of ephrin/Eph signaling in the vasculature and which
agarose gels, PCR products were stained with 10 mg/ml ethidiummechanism is underlying the defects in ephrinB2, ephB4
bromide solution (for pictures shown in Figure 1 and 8) or with SYBRnull, and ephrinBDC/DC mutants? An answer might be pro-
Green Nucleic Acid Gel Stain (Roche). SYBR Green stained products
vided by several other loss-of-function mouse mutants. were quantified using a Fuji FLA-2000 scanner (Aida 2.0 software)
Targeted inactivation of the adhesion molecule VE- and normalized for GAPDH expression. Linear relationship was ob-
Cadherin (Carmeliet et al., 1999), the transcription factor served for amplification results from different dilutions indicating
non-saturating PCR conditions.COUP-TFII (Pereira et al., 1999), Ang-1 (Suri et al., 1996)
Cell
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Wheat Germ Agglutinin Pull Down, Immunoprecipitation, Carmeliet, P., Lampugnani, M.G., Moons, L., Breviario, F., Comper-
nolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oostuyse, B., Dewer-and Western Blotting
Glycosylated proteins in embryo lysates were enriched by pull-down chin, M., et al. (1999). Targeted deficiency or cytosolic truncation
of the VE-cadherin gene in mice impairs VEGF-mediated endothelialwith sepharose-coupled Triticum vulgaris lectin (Sigma, L6257). For
EphB4 stimulation experiments, cultured HUVECs (60% confluent) survival and angiogenesis. Cell 98, 147–157.
were treated with membranes obtained from ephrinB2WT, ephrinB2DC Davy, A., Gale, N.W., Murray, E.W., Klinghoffer, R.A., Soriano, P.,
or empty vector (mock) transfected HEK293 cells or IgG Fc fusion Feuerstein, C., and Robbins, S.M. (1999). Compartmentalized signal-
proteins and analyzed by immunoprecipitation. Samples from pull- ing by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to
down or immunoprecipitation experiments were analyzed by SDS- regulate cellular adhesion. Genes Dev. 13, 3125–3135.
PAGE/immunoblotting with antibodies specific for ephrinB2 (R&D
Dumont, D.J., Gradwohl, G., Fong, G.H., Puri, M.C., Gertsenstein,
Systems, AF496), HA-epitope tag (Babco, PRB-101C), phosphotyro-
M., Auerbach, A., and Breitman, M. (1994). Dominant-negative and
sine (Upstate Biotechnology, clone 4g10), or EphB4 receptor and
targeted null mutations in the endothelial receptor tyrosine kinase,
developed using secondary HRP-coupled antibodies (Amersham)
tek, reveal a critical role in vasculogenesis of the embryo. Genes
and ECL Western Blotting Detection Reagent (Amersham).
Dev. 8, 1897–1909.
Flanagan, J.G., and Vanderhaeghen, P. (1998). The ephrins and EphWhole-Mount Staining with Alkaline Phosphatase
receptors in neural development. Annu. Rev. Neurosci. 21, 309–345.Fusion Proteins
Gale, N.W., and Yancopoulos, G.D. (1999). Growth factors actingFreshly dissected E9.5 embryos were washed three times with ice-
via endothelial cell-specific receptor tyrosine kinases: VEGFs, an-cold PBS (5 min each) and blocked in DMEM, 10% calf serum, and
giopoietins, and ephrins in vascular development. Genes Dev. 13,0.1% NaN3 for 30 min. Incubation with fusion protein (10 nM) of
1055–1066.EphB4 receptor extracellular domain and human secreted alkaline
phosphatase in blocking solution was done overnight (at 48C) fol- Gerety, S.S., Wang, H.U., Chen, Z.F., and Anderson, D.J. (1999).
lowed by washing, heat inactivation of endogenous phosphatases, Symmetrical mutant phenotypes of the receptor EphB4 and its spe-
and color development as described previously (Adams et al., 1999). cific transmembrane ligand ephrinB2 in cardiovascular develop-
ment. Mol. Cell 4, 403–414.
Whole-Mount Immunohistochemistry, lacZ Staining, Helbling, P.M., Saulnier, D.M., and Bra¨ndli, A.W. (2000). The receptor
and In Situ Hybridization tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic
Embryos were fixed with 4% PFA and stained with primary mono- growth of embryonic veins in Xenopus laevis. Development 127,
clonal antibodies against PECAM-1 (Pharmingen, clone MEC13.3, 269–278.
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